At a time when the spread of dengue fever in South America -particularly in Argentina, Brazil, and Paraguay- led the region to seek the Japanese-developed Qdenga vaccine from the Takeda laboratories to tackle the disease, the case of at least five dead and over 100 hospitalized in the Asian insular nation after taking cholesterol-lowering red yeast rice dietary supplements did not go unnoticed.